The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells

The receptor for the urokinase-type plasminogen activator (uPAR) is a widely recognized master regulator of cell migration and uPAR(88–92) is the minimal sequence required to induce cell motility and angiogenesis by interacting with the formyl peptide receptor type 1 (FPR1). In this study, we presen...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Ingangi, Vincenzo, Bifulco, Katia, Yousif, Ali Munaim, Ragone, Concetta, Motti, Maria Letizia, Rea, Domenica, Minopoli, Michele, Botti, Giovanni, Scognamiglio, Giuseppe, Fazioli, Flavio, Gallo, Michele, De Chiara, Annarosaria, Arra, Claudio, Grieco, Paolo, Carriero, Maria Vincenza
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342356/
https://ncbi.nlm.nih.gov/pubmed/27323409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9976
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы